Diagnostic Reagents

Top Page > Diagnostic Reagents > Atlas of Antinuclear Antibodies > Reference

Reference

    Outlines
  1.  Bradwell AR, Stokes RP, Johnson GD. Atlas of HEp-2 patterns. THE BINDING SITE, 1995
  2.  Krapf AR, et al. Atlas of Immunofluorescent Autoantibodies. Urban & Schwarzenberg, 1996
  3.  Mimori T. Structure and function of nuclear and cytoplasmic protein antigens recognized by autoantibodies. Rhumachi 32(4): 366-78, 1992 [Japanese]
  4.  Mimori T. Newly identified autoantibodies and their target autoantigens. Saishin Naikagaku Taikei Progress 4, p146-57. Nakayama Shoten, Tokyo, 1997 [Japanese]

  5. Each autoantibody
  6.  Miyawaki S, Asanuma H. Decreased incidence of peripheral nuclear staining pattern by indirect immunofluorescent antibody technique using HEp-2 cells. Ryumachi 36(4): 644-50, 1996 [Japanese]
  7. Herrera-Diosdado R, Avalos-Diaz E, Herrera-Esparza R. Cross-reactivity of anti-nDNA antibodies with nuclear envelope proteins. Isolation of a cDNA encoding the 70 kDa annular protein recognized by autoantibodies from patients with systemic lupus erythematosus. Rev Rhum Engl Ed 64, 82-8, 1997 [PMID:9085441]
  8.  Ohnishi K, Koike T. Clinical significance of anti-nucleosome antibody in SLE. Relation with lupus nephritis. J Clin and Exp Med. 170(2): 156-7, 1994 [Japanese]
  9. Mizushima N, et al. Two cases of lupus nephritis having a high titer of anti-(histone-DNA) complex antibody without IgG anti-dsDNA antibody. Rinsho Byori 44(6) : 585-9, 1996 [Japanese]
  10.  Sugimoto M. Antibodies to histones in patients with various connective tissue diseases. Jpn. J Clin Immunolog 16(5): 347-54, 1993 [Japanese]
  11.  Mimori T, Suwa A. Ku antigens. Ensho To Meneki 5(3): 291-8, 1997 [Japanese]
  12. Wang J, et al. Human autoantibodies stabilize the quaternary structure of Ku antigen. Arthritis Rheum. 40, 1344-53, 1997 [PMID:9214436]
  13.  Kaburaki J. Screloderma and autoimmune diseases. MBL Autoimmune Reports No.18, p1-13, MBL, Nagoya, 1997 [Japanese]
  14.  Moroi Y. Detection of autoantibodies to centromere and clinical significance. MBL Autoimmune Reports No.7,p1-8, MBL, Nagoya, 1990 [Japanese]
  15. Okazaki T. The structure of centromere. Protein, Nucleic Acid and Enzyme 41(15): 2230-9, 1996
  16.  Tojo T, et al. Small nuclear U-RNP antibodies. Nippon Rinsho 46(4): 784-9, 1988 [Japanese]
  17. Van Venrooij WJ, Sillekens PT. Small nuclear RNA associated proteins: autoantigens in connective tissue diseases. Clin Exp Rheum. 7, 635-45, 1989 [PMID:2692895]
  18.  Brahms H, et al. A major, novel systemic lupus erythematosus autoantibody class recognizes the E, F, and G Sm snRNP proteins as an E-F-G complex but not in their denatured states. Arthritis Rheum. 40, 672-82, 1997 [PMID:9125249]
  19.  Fritzler MJ, Ali R, Tan EM. Antibodies from patients with mixed connective tissue disease react with heterogeneous nuclear ribonucleoprotein or ribonucleic acid (hnRNP/RNA) of the nuclear matrix. J Immunol. 132, 1216-22, 1984 [PMID:6198384]
  20. Steiner G, Skriner K, Smolen JS. Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatic diseases. Int Arch Allergy Immunol. 111, 314-9, 1996 [PMID:8957102]
  21. Montecucco C, et al. Identification of autoantibodies to the I protein of the heterogeneous nuclear ribonucleoprotein complex in patients with systemic sclerosis. Arthritis Rheum. 39, 1669-76, 1996 [PMID:8843857]
  22. Stanek D, et al. Heterogenous nuclear RNP C1 and C2 core proteins are targets for an autoantibody found in the serum of a patient with systemic sclerosis and psoriatic arthritis. Arthritis Rheum 40, 2172-7, 1997 [PMID:9416854]
  23.  Itoh Y. The pathogenesis of neonatal lupus erythematosus and Ro52. Ryumachi 36(4): 884-90, 1996 [Japanese]
  24.  Nishikawa T, et al. Recurrent erythema associated with immunological abnormalities : anti-SS-B recurrent erythema. Nippon Hifuka Gakkai Zasshin 98(8): 825-34, 1988 [Japanese]
  25.  Andrade LE, et al. Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin. J Exp Med. 173, 1407-19, 1991 [PMID:2033369]
  26. Andrade LE, Tan EM, Chan EK. Immunocytochemical analysis of the coiled body in the cell cycle and during cell proliferation. Proc Natl Acad Sci USA. 90, 1947-51, 1993 [PMID:8446613]
  27.  Szostecki C, et al. Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100). Clin exp Immunol 68, 108-16, 1987 [PMID:3308206]
  28. Andre C, et al. The PML and PML/RAR alpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenic. Exp Cell Res. 229, 253-60, 1996 [PMID:8986606]
  29. Zuber M, Heyden TS, Lajous-Petter AM. A human autoantibody recognizing nuclear matrix-associated nuclear protein localized in dot structures. Biol Cell. 85, 77-86, 1995 [PMID:8882521]
  30.  Kuwana M, et al. Clinical significance of anti-nucleolar antibodies detected by immunoprecipitation method in patients with systemic sclerosis. Ryumachi 32(1): 39-46, 1992 [Japanese]
  31.  Imai A. Liver diseases . hepatocellular carcinoma and autoantibodies. MBL Autoimmune Reports No.15, p1-16, MBL, Nagoya, 1995 [Japanese]
  32. Fujii T, Mimori T, Akizuki M. Detection of autoantibodies to nucleolar transcription factor NOR90/hUBF in sera of patients with rheumatic diseases, by recombinant autoantigen-based assays. Arthritis Rheum. 39, 1313-8, 1996 [PMID:8702439]
  33.  Arnett FC, Reveille JD, Valdez BC. Autoantibodies to a nucleolar RNA helicase protein in patients with connective tissue diseases. Arthritis Rheum. 40, 1487-92, 1997 [PMID:9259430]
  34. Valdez BC, et al. A nucleolar RNA helicase recognized by autoimmune antibodies from a patient with watermelon stomach disease. Nucleic Acids Res. 24, 1220-4, 1996 [PMID:8614622]
  35.  Imai H, et al. Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies. Am J Pathol. 140, 859-70, 1992 [PMID:1314027]
  36.  Ochs RL, et al. cDNA cloning and characterization of a novel nucleolar protein. Mol Biol Cell. 7, 1015-24, 1996 [PMID:8862517]
  37.  Takasaki Y. Anti-PCNA antibodies. J Med Technol. 41(5): 529-34, 1997
  38. Hashimoto H, et al. Molecular interaction between proliferating cell nuclear antigen and Ki autoantigen recongnized by sera from patients with systemic lupus erythematosus. Annual report in 1996 Autoimmune diseases research Committee by the Ministry of Health and Welfare, p113-5, 1996 [Japanese]
  39. Takeuchi K, et al. Autoantibodies recognizing proteins copurified with PCNA in patients with connective tissue diseases. Mol Biol Rep. 23, 243-6, 1996 [PMID:9112235]
  40.  Okano T, Mimori T, Akizuki M. The study of a new autoantibody which reacts with a cell cycle dependent nuclear antigen. Jpn J Clin Immun. 14(3): 258-66, 1991 [Japanese]
  41. Okano T, Mimori T. A new autoantibody anti-Na which reacts with a cell cycle-dependent nuclear antigen. Rinsho Byori 45(5): 481-7, 1994 [Japanese]
  42.  Liao H, et al. CENP-F is a protein of the nuclear matrix that assembles onto kinetochores at late G2 and is rapidly degraded after mitosis. J Cell Biol. 130, 507-18, 1995 [PMID:7542657]
  43. Rattner JB, et al. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F. Clin Invest Med. 20, 308-19, 1997 [PMID:9336656]
  44.  Fritzler MJ, et al. An antigen in metaphase chromatin and the midbody of mammalian cells bind to scleroderma sera. J Rheumatol. 14, 291-4, 1987 [PMID:3598998]
  45.  Humbel RL. Detection of antinuclear antibodies by immunofluorescence. in Man Biol Mark A2: 1-16, Kluwer Academic Pubs. Netherlands, 1994
  46.  Tamai K. The apparatus of DNA replication and growth related antigen. Pathol and Clin Med. 9(7): 855-61, 1991 [Japanese]
  47.  Aizawa Y, Toda G. Diversity of antinuclear antibodies and their clinical significance in primary biliary cirrhosis. J Clin and Exp Med. 172(7): 423-6, 1995 [Japanese]
  48. Konstantinov K, et al. Integral membrane proteins associated with the nuclear lamina are novel autoimmune antigens of the nuclear envelope. Clin Immunol Immunopathol. 74, 89-99, 1995 [PMID:7527749]
  49.  von Mikecz A, et al. High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. Arthritis Rheum. 40, 295-305, 1997 [PMID:9041942]
  50. Hill C, et al. Clinical associations of anti-lamin autoantibodies. Aust NZ J Med. 26, 162-6, 1996 [PMID:8744613]
  51. Brito J, et al. Autoantibodies to human nuclear lamin B2 protein. Epitope specificity in different autoimmune diseases. J Immunol. 153, 2268-77, 1994 [PMID:7519647]
  52.  Courvalin JC, Worman HJ. Nuclear envelope protein autoantibodies in primary biliary cirrhosis. Semin Liver Dis. 17, 79-90, 1997 [PMID:9089913]
  53. Wesierska-Gadek J, et al. Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210. J Exp Med. 182, 1159-62, 1995 [PMID:7561689]
  54.  Morifuji T, Kuroda M. Anti-mitochondrial antibody(2). MBL Autoimmune Reports No.9, p1-9, MBL, Nagoya, 1990 [Japanese]
  55. Nishio A, et al. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis. Hepatology. 25, 1085-9, 1997 [PMID:9141421]
  56.  Isshi K, Hirohata S. Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 39, 1483-90, 1996 [PMID:8814059]
  57. Fujimoto M, et al. Anti-ribosomal P protein antibodies in a Japanese patient with systemic sclerosis. J Dermatol. 23, 33-6, 1996 [PMID:8720255]
  58. Uchiumi T. Structure and function of ribosomal autoantigens. Autoantibody and Autoimmunity'97 (Lecture text collection of 4th Symposium of Autoantibody and Autoimmunity). p13-19, MBL, Nagoya, 1997 [Japanese]
  59.  Vazquez-Abad D, Carson JH, Rothfield N. Localization of histidyl-tRNA synthetase (Jo-1) in human laryngeal epithelial carcinoma cell line (HEp-2 cells). Cell Tissue Res. 286, 487-91, 1996 [PMID:8929351]
  60.  Friedman AW, Targoff IN, Arnett FC. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum. 26, 459-67, 1996 [PMID:8870113]
  61.  Hirakata M, et al. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum. 35, 449-56, 1992 [PMID:1567494]
  62.  Griffith KJ, et al. Molecular cloning of a novel 97-kd Golgi complex autoantigen associated with Sjogren's syndrome. Arthritis Rheum. 40, 1693-702, 1997 [PMID:9324025]
  63. Ikonen E, et al. Myosin II is associated with golgi membranes: identification of p200 as nonmuscle myosin II on golgi-derived vesicles. J Cell Sci. 110, 2155-64, 1997 [PMID:9378765]
  64.  Howard MK, Gull K, Miles MA. Antibodies to tubulin in patients with parasitic infections. Clin Exp Immunol. 68, 78-85, 1987 [PMID:3115642]
  65. Connolly AM, Pestronk A. Anti-tubulin autoantibodies in acquired demyelinating polyneuropathies. J Infect Dis. 176 Suppl 2, S157-9, 1997 [PMID:9396702]
  66.  Andrade LE, et al. Two major autoantigen-antibody systems of the mitotic spindle apparatus. Arthritis Rheum. 39, 1643-53, 1996 [PMID:8843854]
  67. Whitehead CM, et al. The spindle kinesin-like protein HsEg5 is an autoantigen in systemic lupus erythematosus. Arthritis Rheum. 39, 1635-42, 1996 [PMID:8843853]
  68.  Rattner JB, et al. Autoantibodies to the centrosome (centriole) react with determinants present in the glycolytic enzyme enolase. J Immunol. 46, 2341-4, 1991 [PMID:1706394]
  69. Sato S, et al. Antibodies to centromere and centriole in scleroderma spectrum disorders. Dermatology. 189, 23-6, 1994 [PMID:8003781]
  70.  Fusconi M, et al. Anti-actin antibodies: a new test for an old problem. J Immunol Methods. 130, 1-8, 1990 [PMID:2193058]
  71. Czaja AJ, et al. requency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology. 24, 1068-73, 1996 [PMID:8903377]
  72.  Cordonnier C, et al. Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor. Br J Rheumatol. 35, 620-4, 1996 [PMID:8670593]
  73.  Kondo H, Suzuki T. Detecting technique of anti-vimentin antibodies and clinical significance. MBL Autoimmune Reports No.5, p1-8, MBL, Nagoya, 1989 [Japanese]
  74.  Wiik AS, et al. Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells. J Autoimmun. 35, 276-90, 2010 [PMID:20650611]
  75.  Nakashima R, et al. The multicenter study of a new assay for simultaneous detection of multiple anti-aminoacyl-tRNA synthetases in myositis and interstitial pneumonia. PLoS One. 9, e85062, 2014 [PMID: 24454792]
  76. Hozumi H, et al. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study. PLoS One. 10, e0120313, 2015 [PMID: 25789468]
  77.  Covini G, et al. Cytoplasmic rods and rings autoantibodies developed during pegylated interferon and ribavirin therapy in patients with chronic hepatitis C. Antivir Ther. 17, 805-11, 2012 [PMID: 22293655]
  78. Carcamo WC, et al. Induction of Cytoplasmic Rods and Rings Structures by Inhibition of the CTP and GTP Synthetic Pathway in Mammalian Cells. PLoS One. 6, e29690, 2011 [PMID: 22220215]
  79. Seelig HP, et al. Autoantibodies against Inosine-5’-Monophosphate Dehydrogenase2 – Characteristics and Prevalence in Patients with HCV-Infection. Clin Lab. 57, 753-65, 2011 [PMID: 22029192]
  80. Liu JL. The enigmatic cytoophidium: compartmentation of CTP synthase via filament formation. Bioessays. 33, 159-64, 2011 [PMID: 21254152]
  81. Alessandra Dellavance, et al. Third Brazilian Consensus for autoantibodies screening in HEp-2 cells (ANA). Recommendations for standardization of autoantibodies screening trial in HEp-2 cells,quality control and clinical associations. Rev Bras Reumatol. 49, 89-109, 2009

↑ TOP


Full Site